About: Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on August 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в серпні 2013 (uk) مقالة علمية نشرت في أغسطس 2013 (ar) scientific article published on August 2013 (en)
publication date	wds:Q37186956-C2811AE7-3AB3-49C9-BB9B-C3A389D48B13
publication date	2013-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37186956-31B2C2A6-C7DA-4BBF-9342-27C7224F196F
language of work or name	English
cites work	wds:Q37186956-06F4F200-0F26-40A3-B4EE-CC46B3C2AA36 wds:Q37186956-0942D1B4-6A8C-43BD-B7F8-7785BC109768 wds:Q37186956-16B49B17-66BA-4FD0-A2BC-C71E00775772 wds:Q37186956-1EB5B9C5-763A-4C8B-ACB0-BED4EDB26691 wds:Q37186956-22B60EDC-867C-4992-AC4C-296D7F3A3728 wds:Q37186956-233DFDE7-F581-4014-B3BA-1AB8779B901F wds:Q37186956-29D8FB6A-65A7-4217-B8BC-6EA1885CB254 wds:Q37186956-3A232953-C042-4E6E-B29A-F2EE6AAE7314 wds:Q37186956-466A6A43-C375-4F69-8DB2-678F20E3325E wds:Q37186956-4F631088-E272-4803-AFE2-4F5DE7AA57A7 wds:Q37186956-58624539-75AA-436A-A606-FA77AB3E4CAE wds:Q37186956-61B0A6B1-1063-4528-9DF6-C2E273A50E57 wds:Q37186956-686CEF00-8102-47E5-BCDA-202C6F71A5D8 wds:Q37186956-79317E62-9F08-40B4-BA78-C6A1F06FADE2 wds:Q37186956-8D980658-CCB3-448D-AF6B-71BBD87F85AF wds:Q37186956-8DF7BB84-0769-4AA2-A573-7F1FDBA2B933 wds:Q37186956-94B99F9A-10EB-4955-B375-1D2EE713E62A wds:Q37186956-A4CB0E49-E4FA-4EB7-91A6-1CEB4305BDC5 wds:Q37186956-B63A1F17-C929-4D39-B803-402544F54747 wds:Q37186956-BA62AD65-0664-42D3-8B1D-35771D89E75D wds:Q37186956-BB7A018D-EE8A-475B-86DC-315F23C8EB25 wds:Q37186956-BB915B60-0844-45DE-94B4-42B03DD6E593 wds:Q37186956-C730C8B1-103D-497C-B0DF-488D0CAFB135 wds:Q37186956-CE6FC83A-46B8-4F4A-B9E0-F7BABFA4EB8A wds:Q37186956-D2AE1197-D3A8-490A-BADF-3E7DDFF7AD82 wds:Q37186956-D456DC3F-F125-4A35-88CD-64DD119379CE wds:Q37186956-E4B167F7-529B-456F-98DC-4B862FCB8ED0 wds:Q37186956-F1002685-D67F-4284-93EC-0E6604C5D3DA
cites work	Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial Early intervention studies in infants and preschool children with cystic fibrosis: are we ready? Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. CDC growth charts: United States A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function Consensus statement for inert gas washout measurement using multiple- and single- breath tests. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis Regression to the mean: what it is and how to deal with it. Multiple-breath washout measurements can be significantly shortened in children Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Comparison of the World Health Organization (WHO) Child Growth Standards and the National Center for Health Statistics/WHO international growth reference: implications for child health programmes Multiple breath nitrogen washout: a feasible alternative to mass spectrometry Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening Airway function in infants newly diagnosed with cystic fibrosis Cystic fibrosis lung inflammation: early, sustained, and severe Structural airway abnormalities in infants and young children with cystic fibrosis. Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung disease A realistic validation study of a new nitrogen multiple-breath washout system Age and height dependence of lung clearance index and functional residual capacity. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening Feasibility and variability of measuring the Lung Clearance Index in a multi-center setting
author name string	wds:Q37186956-0B7BFA3C-3B37-4D2A-84E3-B1CA4D5C6033 wds:Q37186956-0C780EC0-3210-46BA-B66F-6FF4D5E9DF12 wds:Q37186956-24703D81-29C4-4F1F-BEF0-7D22C39D7305 wds:Q37186956-2AC293AB-C617-4743-A211-B817A8207DCA wds:Q37186956-6B3CA015-7634-4872-9ED4-B2C0BF9377B7 wds:Q37186956-AF31E8A4-82D8-4DBD-909F-56748F980A87
author name string	Margaret Rosenfeld Per Gustafsson Lyndia Brumback Stephanie Davis Sanja Stanojevic Meghan Brown
rdfs:label	Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline (en) Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline (ast) Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. (nl)
skos:prefLabel	Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline (en) Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline (ast) Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. (nl)
name	Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline (en) Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline (ast) Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. (nl)
author	wds:Q37186956-28540454-1107-48FA-AE3A-E087B295E209 wds:Q37186956-5348136B-5FA7-415C-9F9F-8C8A1069356C

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software